ALLIED HEALTH FLOURISHES IN REGIONAL AND RURAL VICTORIA Gen Health Hamilton serves local community and rural outreach with range of allied health services
With
Jessica Fishburn,
Physiotherapist & Director
Gen Health Hamilton, Victoria
Carl Joyce,
Podiatrist & Director
Gen Health Hamilton, Victoria
AUSTRALIAN HEALTH JOURNAL SEGMENT
Filmed in Hamilton, Victoria | April 2025
Genhealth Hamilton was established in 2015 in regional and rural Victoria. The practice offers a range of services including physiotherapy, podiatry, occupational therapy, exercise science, and group classes such as clinical reformer therapy and clinical Pilates in Hamilton, which has a population of around 10,000. The clinic also serves a wider community within 100 kilometre, reaching rural residents and local industries.
The clinic caters to both private-paying patients and compensable clients referred by GPs or government-funded programs like NDIS and WorkCover. They address various health concerns, particularly in women’s pelvic health, with the clinic being one of the few in the region that specialises in this area.
Genhealth’s mission is to strengthen the health of the local community through a collaborative approach, allowing patients to access multiple services in one location. The multidisciplinary team is notably young and dynamic, contributing a vibrant energy to their healthcare delivery. The clinic has successfully reached approximately 9,000 of the 10,000 people in the community, showcasing their commitment to improving health outcomes.
The founders, initially four young women, took the risk to realise their vision for allied healthcare, turning it into a successful and community-focused business.
Australian Health Journal spoke with two Directors about the practice, the staff and the community they serve.
Source: Written by AUDIENCED from transcript
Filming credit: The Social Connection
-
Clinical Trials in Australia
Shanny Dyer, CEO ARCS Australia talks about a recent summit where the CRO (Contract Research Organization) community was asked on the current state of clinical trials in Australia.
-
Cardinal Health brings device reprocessing plant to Australia
Cardinal Health is global medical products manufacturer and leading provider of single-use device reprocessing services in the U.S. In Australia and New Zealand, as one of the largest suppliers of medical devices, announced on 23 May 2024 that it will be opening a single-use medical device reprocessing facility in Australia – its first reprocessing facility outside the United States.
On 18 March 2025 at the Health Innovation Living Lab at the John Hunter Hospital, a further announcement was made, on the chosen single-use medical device remanufacturing facility in Beresfield, Newcastle, set to commence operation late 2025, supported by the NSW Department of Primary Industries and Regional Development.
-
Confronting picture of growing women’s health crisis in uterine cancers
Uterine cancers have become Australia’s fastest-growing women’s cancer, with incidence doubling over the past 25 years and projected to continue to surge. Without immediate action, more than 44,000 women are expected to be diagnosed by 2035, and 8,900 will lose their lives to the disease.
Released November 2025, Australia’s first State of the Nation: Uterine Cancers in Australia 2025 report by the Australia New Zealand Gynaecological Oncology Group (ANZGOG), reveals a confronting picture of a growing women’s health crisis that has gone largely unseen and one that now requires immediate, coordinated national action.
